Cargando…
Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy
Cancer patients undergoing paclitaxel infusion usually experience peripheral nerve degeneration and serious neuropathic pain termed paclitaxel-induced peripheral neuropathy (PIPN). However, alterations in the dose or treatment schedule for paclitaxel do not eliminate PIPN, and no therapies are avail...
Autores principales: | Wu, Zizhen, Toro, Gabor, Xu, Guoying, Dang, Danny, Prater, Charmaine, Yang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9776748/ https://www.ncbi.nlm.nih.gov/pubmed/36552832 http://dx.doi.org/10.3390/cells11244067 |
Ejemplares similares
-
Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
por: Brazill, Jennifer M., et al.
Publicado: (2018) -
Activation of peripheral KCNQ channels attenuates inflammatory pain
por: Hayashi, Hiroki, et al.
Publicado: (2014) -
Activation of peripheral KCNQ channels relieves gout pain
por: Zheng, Yueming, et al.
Publicado: (2015) -
Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021) -
Mechanisms Underlying Modulation of Neuronal KCNQ2/KCNQ3 Potassium Channels by Extracellular Protons
por: Prole, David L., et al.
Publicado: (2003)